µ¼Ê¦ÐÕÃû£ºÀî´ïÁŠ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º617
ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÖÐҩѧԺ
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÌìȻҩÎﻯѧ¡¢Ò©Ñ§£¨ÌìȻҩÎﻯѧ·½Ïò£©
Ñо¿ÁìÓò£º Ò»£ºÌìÈ»À´Ô´»îÐÔÏȵ¼·Ö×ӵķ¢ÏÖÓë»ñµÃ¼°¸´ÔӽṹµÄÈ·Ö¤Ñо¿·½Ïò¶þ£ºÌìÈ»À´Ô´Ïȵ¼»¯ºÏÎïµÄ³ÉÒ©ÐÔ... [Õ¹¿ª]
Ñо¿ÁìÓò£º Ò»£ºÌìÈ»À´Ô´»îÐÔÏȵ¼·Ö×ӵķ¢ÏÖÓë»ñµÃ¼°¸´ÔӽṹµÄÈ·Ö¤Ñо¿·½Ïò¶þ£ºÌìÈ»À´Ô´Ïȵ¼»¯ºÏÎïµÄ³ÉÒ©ÐÔ¸ÄÔì¡¢»îÐÔÆÀ¼ÛºÍ×÷ÓûúÖÆÑо¿Ñо¿·½ÏòÈý£º»ùÓÚ¹¦ÄÜʳƷµÄÎïÖÊ»ù´¡¼°Æä×÷ÓûúÖÆµÄ²úÆ·Ñз¢ [ÊÕÆð]
ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºlidahong0203@163.com
ͨѶµØÖ·£ºÉòÑôÊÐÉòºÓÇøÎÄ»¯Â·103ºÅ
¸öÈ˼òÊö :
Àî´ïÁŠ£¬ÄУ¬²©Ê¿£¬¸±½ÌÊÚ¡£2007Äê±ÏÒµÓÚÉòÑôÒ©¿Æ´óѧ£¬»ñÀíѧѧʿѧ룬2010ÄêÓÚͬУ»ñÒ©Îﻯѧ˶ʿѧ룬2013Äê»ñÖйúÒ©¿Æ´óѧҩÎﻯѧ²©Ê¿Ñ§Î»£¬Í¬Äê»ØÄ¸Ð£ÖÐҩѧԺÌìȻҩÎﻯѧ½ÌÑÐÊÒÈν̡£2014Äê11ÔÂÖÁ½ñ£¬½øÐв©Ê¿ºóÑо¿¹¤×÷¡£2015Äê10ÔÂÖÁ2016Äê3Ô¸°ÈÕ±¾Ñо¿½»Á÷¡£2016Äê12Ô±»Æ¸Îª¸±½ÌÊÚ¡£×÷Ϊ¿ÎÌ⸺ÔðÈËÖ÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÇàÄê»ù½ðÏîÄ¿1Ï¹ú¼Ò²©Ê¿ºó¿ÆÑ§»ù½ðÃæÉÏ×ÊÖú£¨Ò»µÈ£©1ÏÁÉÄþÊ¡×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿1ÏÁÉÄþÊ¡½ÌÓýÌü¿ÆÑ§Ñо¿Ò»°ãÏîÄ¿1ÏÉòÑôÒ©¿Æ´óѧ¿ÆÑÐרÏî»ù½ð1ÏÉòÑôÒ©¿Æ´óѧÖÐÇàÄê½ÌʦÊÂÒµ·¢Õ¹Ö§³Ö¼Æ»®ÏîÄ¿1Ïʡ²¿¼¶ÖصãʵÑéÊÒ¿ª·Å¿ÎÌâ2Ï´ËÍ⣬×÷ΪÏîÄ¿¹Ç¸É³ÉÔ±²ÎÓë¡°Ê®ÈýÎ塱¿Æ¼¼²¿ÖØ´óרÏî¿ÎÌâ1Ï¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿2ÏĿǰÒÑÔÚJ. Med. Chem., Org. Lett., J. Nat. Prod., Eur. J. Med. Chem., Phytochemistry, Bioorg. Med. Chem., J. Funct. FoodsµÈÒ©Îﻯѧ¡¢ÌìȻҩÎﻯѧºÍʳƷ¿ÆÑ§ÁìÓòºËÐÄÆÚ¿¯·¢±íSCIÂÛÎÄ50ÓàÆª¡£
¿ÆÑй¤×÷ :
1.Tong Han, Jia Li, Jing-Jing Xue, He Li, Fan-Xing Xu*, Ke-Guang Cheng, Da-Hong Li*, Zhan-Lin Li, Ming Gao, Hui-Ming Hua*. Scutellarin derivatives as apoptosis inducers: design, synthesis and biological evaluation. Eur. J. Med. Chem. 2017, 135, 270-281. (IF=3.902)2.Kang-Tao Tian#, Fan-Xing Xu#, Xiang Gao, Tong Han, Jia Li, Hua-Qi Pan*, Ling-He Zang, Da-Hong Li*, Zhan-Lin Li, Takahiro Uchita, Ming Gao, Hui-Ming Hua*. Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents. Eur. J. Med. Chem. 2017, 136, 131-143. (IF=3.902)3.Kai-Bo Wang#, Da-Hong Li#, Yu Bao, Fei Cao, Wen-Jing Wang, Clement Lin, Wen Bin, Jiao Bai, Yue-Hu Pei, Yong-Kui Jing, Dan-Zhou Yang*, Zhan-Lin Li*, Hui-Ming Hua*. Structurally diverse alkaloids from the seeds of Peganum harmala. J. Nat. Prod. 2017, 80(2), 551-559. (if 3.662)4.Sheng-Tao Xu, Hong Yao, Shan-Shan Luo, Yun-Kai Zhang, Dong-Hua Yang, Da-Hong Li, Guang-Yu Wang, Mei Hu, Yang-Yi Qiu, Xiao-Ming Wu, He-Quan Yao*, Wei-Jia Xie, Zhe-Sheng Chen*, Jin-Yi Xu*. A novel potent anticancer compound optimized from a natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway. J. Med. Chem. 2017, 60(4), 1449-1468. (if 5.589)5.Kai-Bo Wang, Da-Hong Li, Ping Hu, Wen-Jing Wang, Clement Lin, Jian Wang, Bin Lin, Jiao Bai, Yue-Hu Pei, Yong-Kui Jing, Zhan-Lin Li*, Danzhou Yang*, Hui-Ming Hua*. A series of ¦Â-carboline alkaloids from the seeds of Peganum harmala show G-quadruplex interactions. Org. Lett. 2016,18, 3398-3401. (if 6.732)6.Yan Bai#, Da-Hong Li#, Ting-Ting Zhou, Ning-Bo Qin, Zhan-Lin Li, Zhi-Guo Yu*, Hui-Ming Hua*. Coumarins from the roots of Angelica dahurica with antioxidant and antiproliferative activities. J. Funct. Foods 2016, 20, 453-462. (if 3.973)7.Nan Zhao, Kang-Tao Tian, Ke-Guang Cheng, Tong Han, Xu Hu, Da-Hong Li*, Zhan-Lin Li, Hui-Ming Hua*. Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine. Bioorg. Med. Chem. 2016, 24, 2971-2978. (if 2.923)8.Chun-Mei Sai, Da-Hong Li, Chun-Mei Xue, Kai-Bo Wang, Ping Hu, Yue-Hu Pei, Jiao Bai, Yong-Kui Jing, Zhan-Lin Li*, Hui-Ming Hua*. Two pairs of enantiomeric alkaloid dimers from Macleaya cordata. Org. Lett. 2015,17, 4102-4105. (if 6.732)9.Da-Hong Li, Hao Cai, Bo-Wen Jiang, Gu-Yue Liu, Yue-Tong Wang, Lei Wang, He-Quan Yao, Xiao-Ming Wu*, Yi-Jun Sun, Jin-Yi Xu*. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells. Eur. J. Med. Chem. 2013, 59, 322-328. (if 3.432)10.Da-Hong Li#, Sheng-Tao Xu#, Hao Cai, Ling-Ling Pei, Heng-Yuan Zhang, Lei Wang, He-Quan Yao, Xiao-Ming Wu, Jie-Yun Jiang, Yi-Jun Sun, Jin-Yi Xu*. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: synthesis and their antitumor biological evaluation. Eur. J. Med. Chem. 2013, 64, 215-221. (if 3.432)Ö÷±à»ò²Î±àµÄ½Ì²Ä¡¢×¨Öø1.¡¶ÌìȻҩÎﻯѧѧϰָµ¼ÓëϰÌ⼯¡·µÚËİæ²Î±à£¬¹ú¼ÒÊ®ÈýÎ广»®½Ì²Ä¡£ÈËÃñÎÀÉú³ö°æÉç¡£2016Äê2ÔÂרÀû¼°ÆäËû1.Àî´ïÁŠ£¬»ª»áÃ÷£¬ÀîÕ¼ÁÖ£¬ÕÔ骣¬Ì￵ÌΣ¬º«Í¨£¬ºúÐñ£¬·½´ºÑÞ.Ò»Àà¾ßÓп¹Ö×Áö»îÐÔµÄÏõËáõ¥ÀàNO¹©ÌåÐÍÎâÜïÝǼîÑÜÉúÎï.CN**7.12.Àî´ïÁŠ£¬»ª»áÃ÷£¬ÀîÕ¼ÁÖ£¬ÕÔ骣¬Ì￵ÌΣ¬º«Í¨£¬ºúÐñ£¬·½´ºÑÞ.Ò»Àà¾ßÓп¹Ö×Áö»îÐÔµÄß»ÔÛÀàNO¹©ÌåÐÍÎâÜïÝǼîÑÜÉúÎï.CN**0.73.Ðì½øÒË£¬Àî´ïÁŠ£¬²ÌºÆ£¬ÍõÀÚ£¬ÐìÊ¢ÌΣ¬Ëï·É£¬Ò¦ºÍȨ£¬½¯½àÔÆ£¬ËïÒæ¾ü.¾ßÓп¹Ö×Áö»îÐԵͬÁè²Ý¼×ËØ¼°6,7-¿ª»·¶¬Áè²Ý¼×ËØº¬·úÑÜÉúÎï¡¢ÖÆ±¸·½·¨¼°ÓÃ;.CN**8.04.Ðì½øÒË£¬ÐìÊ¢ÌΣ¬Àî´ïÁŠ£¬Íõ³ÏÙ»£¬Ò¦ºè£¬ÅáÁáÁᣬ³ÂÕÜÉú£¬ÕÅÔËê]£¬ÕźãÔ´£¬Õų¿êØ.¶¬Áè²Ý¼×ËØ14-O-È¡´úµª½æÑÜÉúÎï¡¢ÖÆ±¸·½·¨¼°ÓÃ;.CN**2.95.Ðì½øÒË£¬Àî´ïÁŠ£¬ÐìÊ¢ÌΣ¬ÖÜÖ¾ÎÄ£¬ÕźãÔ´£¬²ÌºÆ£¬ÑîÑ©£¬ÅáÁáÁᣬҦºÍȨ£¬ÎâÏþÃ÷£¬Ð»Î¨¼Ñ.1,6,7,14-λȡ´úµÄ¶¬Áè²Ý¼×ËØÑÜÉúÎï¡¢ÖÆ±¸·½·¨¼°ÓÃ;.CN**5.16.Ðì½øÒË£¬ÐìÊ¢ÌΣ¬ÅáÁáÁᣬÀî´ïÁŠ£¬Ò¦ºè£¬²ÌºÆ£¬ÖÜÖ¾ÎÄ£¬ÕźãÔ´£¬ÑîÑ©£¬Ò¦ºÍȨ£¬ÎâÏþÃ÷£¬Ð»Î¨¼Ñ.¶¬Áè²Ý¼×ËØ¼°Æäent-6,7-¿ª»·±´¿ÇɼϩÐÍÑÜÉúÎïÔÚÖÆ±¸¿¹½áºËÒ©Îï·½ÃæµÄÓÃ;.CN**9.X7.Ðì½øÒË£¬ÍõÀÚ£¬ÕÅÞÈ»ª£¬Ò¦ºÍȨ£¬Àî´ïÁŠ£¬ÐìÊ¢ÌΣ¬»ÆÏþ¾²£¬ÕźãÔ´£¬ÀîµÂÒ¢£¬¹ù½¨Âü£¬Íõ¹ú²Æ.Ò»Ñõ»¯µª¹©ÌåÐͶ¬Áè²Ý¼×ËØ14λôÇ»ùÐÞÊÎÑÜÉúÎï¡¢ÆäÖÆ±¸·½·¨¼°ÓÃ;.CN**2.X8.»ª»áÃ÷£¬ËÕîÚÇ壬Âí¶¬çæ£¬ÀîÊ¥¸÷£¬Àî´ïÁŠ£¬ÀÓ£¬¹ù¼Ñ.ÂíβÁ¬ÖÐÁ½¸öº¬ÂÈÈ¡´úµÄ¿¹Ö×ÁöÜлùÒìàßøÉúÎï¼î.CN**4.79.Ðì½øÒË£¬Ïô࣬ÀîÔÞ£¬¶¡¸Ú£¬Àî´ïÁŠ£¬ÃÏÕ×Ç࣬ÍõÕñÖУ¬²ÜÁÁ£¬ÀîÄÈ£¬ÁõÎľý.Ò»ÖÖ¿¹Ö×Áö¡¢¿¹²¡¶¾µÄ»¯ºÏÎï¡¢ÆäÖÆ±¸·½·¨¼°ÓÃ;.CN**4.4
ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Àî´ïÁŠ
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/ÌìȻҩÎﻯѧ ÉòÑôÒ©¿Æ´óѧ Ò©Îﻯѧ ²©Ê¿ºó ½á¹¹
ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÂíÄþÄþ
µ¼Ê¦ÐÕÃû£ºÂíÄþÄþÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º573ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÎÞÑÄѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢Î¢ÉúÎïÓëÉú»¯Ò©Ñ§¡¢ÖÆÒ©¹¤³Ì¡¢Ò©Ñ§£¨Î¢ÉúÎïÓëÉú»¯Ò©Ñ§·½Ïò£©Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÉúÎïÖÆÒ©¹¤³Ì£¬Ï¸°û»ùÒò¹¤³ÌºÍ´úл¹¤³Ì¸ÄÔì;Ñо¿·½Ïò¶þ£º¿¹ÌåºÍÖØ×éµ°°×Ò©ÎïÑо¿Ñо¿ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÅΪ¸ï
µ¼Ê¦ÐÕÃû£ºÕÅΪ¸ïÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º518ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÆÒ©¹¤³ÌѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÓлú»¯Ñ§¡¢ÖÆÒ©¹¤³Ì¡¢Ò©Îﻯѧ¡¢ÁÙ´²Ò©Ñ§¡¢Ò©Ñ§£¨Ò©Îﻯѧ·½Ïò£©¡¢¹¤³Ì˶ʿ£¨ÖÆÒ©¹¤³ÌÁìÓò£©Ñо¿ÁìÓò£ºÒ»£º»ùÓڰеã´ó·Ö×Ó/»îÐÔС·Ö×ӵĴ´ÐÂÒ©ÎïÑо¿Ñо¿·½Ïò¶þ£ºÓлú·´Ó¦·½·¨ÓëÂÌÉ«»¯Ñ§¼¼ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀîÄþ
µ¼Ê¦ÐÕÃû£ºÀîÄþÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º485ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÐҩѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖ²Îïѧ¡¢ÌìȻҩÎﻯѧ¡¢Ò©Ñ§£¨ÌìȻҩÎﻯѧ·½Ïò£©¡¢¹¤³Ì˶ʿ£¨Ê³Æ·¹¤³ÌÁìÓò£©Ñо¿ÁìÓò£ºÒ»£ºÌìÈ»À´Ô´°©Ö¢»¯Ñ§Ô¤·À¼ÁµÄ·¢ÏÖºÍÆä»ùÓÚmiRNAsµ÷¿ØµÄ×÷ÓûúÖÆÑо¿Ñо¿·½Ïò¶þ£º·ÀÖΰ¢¶û...[Õ¹ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¼Ö¾°Ã÷
µ¼Ê¦ÐÕÃû£º¼Ö¾°Ã÷ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º459ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÐҩѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÖÐÒ©×ÊԴѧ¡¢ÖÐÒ©ÉúÎï¼¼Êõѧ¡¢ÖÐÒ©¼ø¶¨Ñ§¡¢ÖÐҩѧ£¨ÖÐÒ©¼ø¶¨Ñ§·½Ïò£©¡¢ÖÐҩѧ£¨ÖÐÒ©×ÊԴѧ·½Ïò£©¡¢ÖÐҩѧ£¨ÖÐÒ©ÉúÎï¼¼Êõѧ·½Ïò£©Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÖÐÒ©×ÊԴѧ£»Ñо¿·½Ïò¶þ£ºÖÐÒ©ÉúÎï¼¼Êõ£» ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Õž°º£
µ¼Ê¦ÐÕÃû£ºÕž°º£ÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º427ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÉúÃü¿ÆÑ§ÓëÉúÎïÖÆÒ©Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢Î¢ÉúÎïÓëÉú»¯Ò©Ñ§¡¢Ò©Ñ§£¨Î¢ÉúÎïÓëÉú»¯Ò©Ñ§·½Ïò£©¡¢Ò½ÁÆÆ÷е¹¤³ÌÑо¿ÁìÓò£ºÒ»£ºÒ©Ñ§¡¢ÖÐҩѧÉúÎﻯѧ/·Ö×ÓÉúÎïѧÑо¿·½Ïò¶þ£ºÉúÎï¼¼ÊõÔÚҩѧ¡¢ÖÐҩѧµÄÓ¦ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÀîΡ
µ¼Ê¦ÐÕÃû£ºÀîΡÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º398ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£º¹¦ÄÜʳƷÓëÆÏÌѾÆÑ§ÔºÖ°³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÌìȻҩÎﻯѧ¡¢Ò©Ñ§£¨ÌìȻҩÎﻯѧ·½Ïò£©¡¢¹¤³Ì˶ʿ£¨Ê³Æ·¹¤³ÌÁìÓò£©Ñо¿ÁìÓò£ºÒ»£º»îÐÔÌìÈ»²úÎï¼°ÐÂʳƷ×ÊÔ´ºÍ¹¦ÄÜʳƷµÄÑо¿¿ª·¢Ñо¿·½Ïò¶þ£º¾ßÓиÄÉÆÉñ¾ÍËÐÐÐÔ¼²²¡µÄÌìÈ»²ú...[Õ¹ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Ñî¾²Óñ
µ¼Ê¦ÐÕÃû£ºÑî¾²ÓñÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º388ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÉúÃü¿ÆÑ§ÓëÉúÎïÖÆÒ©Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ¡¢ÁÙ´²Ò©Ñ§¡¢ÖÐÒ©Ò©Àíѧ¡¢Ò©Ñ§(ÁÙ´²Ò©Ñ§Ñо¿·½Ïò)¡¢Ò©Ñ§(Ò©ÀíѧÑо¿·½Ïò)¡¢ÖÐҩѧ(ÖÐÒ©Ò©ÀíѧÑо¿·½Ïò)Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÉñ¾ÍËÐÐÐÔ¼²²¡¡¢¾«ÉñÕϰµÈ¼²²¡µÄ·¢²¡ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-º«ÄÈ
µ¼Ê¦ÐÕÃû£ºº«ÄÈÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º375ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÐҩѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúҩѧ¡¢Ò©Ñ§£¨Éúҩѧ·½Ïò£©Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÉúÒ©»îÐÔÌìÈ»²úÎïµÄ¿ª·¢ÓëÀûÓÃ;Ñо¿·½Ïò¶þ£ºÖÐÒ©¸´·½µÄ×÷ÓûúÀíÑо¿Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÉúÒ©»îÐÔÌìÈ»²úÎïµÄ¿ª·¢ÓëÀûÓÃ;Ñо¿·½Ïò¶þ£ºÖÐÒ©¸´·½µÄ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÕÔÓàÇì
µ¼Ê¦ÐÕÃû£ºÕÔÓàÇìÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º352ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£º¹¦ÄÜʳƷÓëÆÏÌѾÆÑ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢ÌìȻҩÎﻯѧ¡¢Ò©Ñ§£¨ÌìȻҩÎﻯѧ·½Ïò£©¡¢ÖÐÒ©»¯Ñ§¡¢ÖÐҩѧ£¨ÖÐÒ©»¯Ñ§·½Ïò£©¡¢¹¤³Ì˶ʿ£¨Ê³Æ·¹¤³ÌÁìÓò£©Í¨Ñ¶·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºzyq4885 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Õŷソ
µ¼Ê¦ÐÕÃû£ºÕŷソÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º330ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÎÞÑÄѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ¡¢Ò©Ñ§£¨Ò©Àíѧ·½Ïò£©Ñо¿ÁìÓò£ºÒ»£º»îÐÔÑõ½éµ¼µÄ·Ö×Ó¶¾ÀíѧÑо¿Ñо¿·½Ïò¶þ£º»îÐÔÑõÏà¹Ø¼²²¡£¨ÌÇÄò²¡¡¢ÑªË¨¡¢Ö×ÁöµÈ£©µÄ°ÐµãÑо¿...[Õ¹¿ª]Ñо¿ÁìÓò£ºÒ»£º»îÐÔÑõ½éµ¼µÄ·Ö×Ó¶¾ÀíѧÑÐ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ºîÏþºç
µ¼Ê¦ÐÕÃû£ººîÏþºçÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º320ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÆÒ©¹¤³ÌѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º·ÖÎö»¯Ñ§¡¢Ò©Îï·ÖÎöѧ¡¢»·¾³»¯¹¤¡¢Ò©Ñ§£¨Ò©Îï·ÖÎöѧ·½Ïò£©Í¨Ñ¶·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºhouxiaohong@syphu.edu.cnͨѶµØÖ·£ºÁÉÄþÊ¡±¾Ïª¸ßм¼Êõ²úÒµ¿ª·¢Çø»ª ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¼ÖÓ¢
µ¼Ê¦ÐÕÃû£º¼ÖÓ¢ÐÔ±ð£ºÅ®ÈËÆøÖ¸Êý£º316ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£º¹¦ÄÜʳƷÓëÆÏÌѾÆÑ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúҩѧ¡¢Ò©Ñ§£¨Éúҩѧ·½Ïò£©¡¢ÖÐÒ©·ÖÎöѧ¡¢ÖÐҩѧ£¨ÖÐÒ©·ÖÎöѧ·½Ïò£©Ñо¿ÁìÓò£ºÑо¿·½ÏòÒ»£ºÖÐҩҩЧÎïÖÊ»ù´¡¡¢ÖÐÒ©ÖÊÁ¿¿ØÖÆÓëÖÊÁ¿ÆÀ¼Û¼°ÖÐÒ©»îÐԳɷִúл×éѧÑо¿£»Ñо¿·½Ïò¶þ... ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÏÄ»ÀÕÂ
µ¼Ê¦ÐÕÃû£ºÏÄ»ÀÕÂÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º309ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÉúÃü¿ÆÑ§ÓëÉúÎïÖÆÒ©Ñ§ÔºÖ°³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÎ¢ÉúÎïѧ¡¢Î¢ÉúÎïÓëÉú»¯Ò©Ñ§¡¢Ò©Ñ§£¨Î¢ÉúÎïÓëÉú»¯Ò©Ñ§·½Ïò£©Ñо¿ÁìÓò£ºÒ»£º×éºÏÉúÎïºÏ³ÉÑо¿Ñо¿·½Ïò¶þ£ºÎ¢ÉúÎï´Î¼¶´úл²úÎïÉúÎïºÏ³É»ùÒòµÄÑо¿£»Ñо¿·½ÏòÈý£ºÀûÓÃϵͳ...[Õ¹ ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-ÏîÈÙÎä
µ¼Ê¦ÐÕÃû£ºÏîÈÙÎäÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º308ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÒ½ÁÆÆ÷еѧԺְ³Æ£º½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÁÙ´²Ò©Ñ§¡¢Ò©Ñ§ÐÅϢѧ¡¢Ò©Ñ§£¨ÁÙ´²Ò©Ñ§·½Ïò£©Í¨Ñ¶·½Ê½:°ì¹«µç»°£º**£»**µç×ÓÓʼþ£ºxrwlove@163.comͨѶµØÖ·£ºÁÉÄþÊ¡±¾Ïª¸ßм¼Êõ²úÒµ¿ª·¢Çø»ªÙ¢´ó½Ö26ºÅ¸öÈ˼òÊö:ÏîÈÙÎ䣬 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27ÉòÑôÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-Áõ¶«´º
µ¼Ê¦ÐÕÃû£ºÁõ¶«´ºÐÔ±ð£ºÄÐÈËÆøÖ¸Êý£º287ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧËùÊôԺϵ£ºÖÐҩѧԺְ³Æ£º¸±½ÌÊÚµ¼Ê¦ÀàÐÍ£ºË¶µ¼ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÉúҩѧ¡¢ÖÐÒ©ÖÆ¼Áѧ¡¢ÖÐҩѧ£¨ÖÐÒ©ÖÆ¼Áѧ·½Ïò£©¡¢Ò©Ñ§£¨Éúҩѧ·½Ïò£©Í¨Ñ¶·½Ê½:°ì¹«µç»°£º**µç×ÓÓʼþ£ºliudongchun@outlook.comͨѶµØÖ·£ºÉòÑôÊÐÉòºÓÇøÎÄ»¯Â·103ºÅ93 ...µ¼Ê¦ÐÅÏ¢ ±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2019-05-27
